Search

Displaying results 141 to 150 of 234.

Pages

Prof Dr Alice McHardy

Prof Dr Alice McHardy Head of Research Group +49 531 391-55271 E-Mail Alice Carolyn McHardy holds a diploma in biochemistry and a doctoral degree (Dr. rer. nat) in bioinformatics, both from Bielefeld University in Germany. From 2005 to 2007 she first was a…

Pages

Prof. Dr. Till Strowig

Prof Dr Till Strowig Head of Research Group +49 531 6181-4700 E-Mail Till Strowig studied Medical Biotechnology at the “Technische Universität” Berlin. After his diploma thesis at The Rockefeller University in New York, he remained there for his Ph.D.…

Pages

Prof. Dr. Wulf Blankenfeldt

Prof Dr Wulf Blankenfeldt Head of Department +49 531 6181-7000 E-Mail Wulf Blankenfeldt studied chemistry at the Technische Universität Braunschweig (TU) and earned his doctorate in “Crystal structure analysis of tyrosine aminotransferase from Trypanosoma…

Pages

Prof. Dr. Dr. h.c. Dirk Heinz

Prof Dr Dr h.c. Dirk Heinz Head of Department +49 531 6181-3700 E-Mail Dirk Heinz is a German biochemist and structural biologist. He studied chemistry in Freiburg/Germany and received his PhD in structural biology from the University of Basel/Switzerland.…

Pages

Prof. Dr. Luka Cicin-Sain

Prof Dr Dr Luka Cicin-Sain Head of Research Group +49 531 6181-4608 E-Mail Born in Croatia, Luka Cicin-Sain studied medicine at the University of Rijeka, his hometown. In 1996, he received his M.D. After that he studied biomedicine and spent a year as a…

Research Group

Human-Microbe Systems Bioinformatics

The human body encompasses fewer human cells than microbes. They constantly interact with each other and the host and greatly affect an individual's health and well-being. In our group, we develop and apply state-of-the-art bioinformatics software to study the human-microbe systems and aim to discover natural products involved in communication between the two realms. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) .

Research Group

Genome Mining for Secondary Metabolites

The misuse of antibiotics on a global scale has led to an ever-growing antibiotic resistance crisis. Novel antimicrobial compounds are urgently needed. Microorganisms are considered to be one of the most prolific sources for natural product drugs including antibiotics. Developing novel genome mining approaches to harness the potential of the underexplored biosynthetic gene pathways and discover novel microbial natural products, is a potential antibiotic resistance crisis mitigation path. This group is located at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) .

Research Group

Experimental Infection Research

If we are attacked by a virus, the immune system reacts within a matter of hours. Highly specialized immune cells recognise the pathogen and release highly efficient messengers, which activate the immune system. These messengers include the interferons, which ensure that individual host cells are mildly infected . At the same time, interferons can also influence the course of the immune response and the memory of the immune system. Without these messengers virus infections - which we normally overcome almost unnoticeably - become fatal within just a few days. The group Experimental Infection Research is based at the TWINCORE in Hannover.

Research Group

Evolutionary Community Ecology

Humans are increasingly part of these interaction networks and pathogen transmission from animals to humans is occurring at increasing rates. Indeed, emerging zoonotic disease are an increasing threat to human health and most of these diseases have their origins in wildlife. Microorganisms and their associated diseases also influence animal populations’ persistence and conservation, with some spilling over to animals from humans as well. The research group ‘evolutionary community ecology’ explores how the changing composition of animal communities has cascading impacts on their microbial communities, diseases, and rates of transmission, including to humans. The department is located at the Helmholtz Institute for One Health .